Prestige BioPharma Limited (KRX:950210)
South Korea · Delayed Price · Currency is KRW 11,650
+390 (3.46%)
At close: Feb 6, 2026
-20.59% (1Y)
| Market Cap | 140.02B -24.1% |
| Revenue (ttm) | 14.41B +406.9% |
| Net Income | 15.76B |
| EPS | 262.37 |
| Shares Out | 12.02M |
| PE Ratio | 44.40 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 204,105 |
| Average Volume | 155,595 |
| Open | 11,220 |
| Previous Close | 11,260 |
| Day's Range | 10,820 - 11,690 |
| 52-Week Range | 10,550 - 20,000 |
| Beta | 0.84 |
| RSI | 47.17 |
| Earnings Date | Feb 27, 2026 |